Pharma Stocks
-
Merck: Buy The Dip On This Dividend Growth Pharma Leader (NYSE:MRK)
This article was written by Follow I am Gen Alpha. I have more than 14 years of investment experience, and…
Read More » -
Do Sumitomo Pharma’s (TSE:4506) Hematology Updates Hint At A Deeper R&D Repositioning?
Sumitomo Pharma America recently presented early clinical and translational findings at the European Hematology Association 2026 Congress, including preliminary data…
Read More » -
Why Is Rhythm Pharma Stock Jumping Today? – Rhythm Pharmaceuticals (NASDAQ:RYTM)
The six-month data shared on Saturday showed improvements in body mass index, body composition, hyperphagia, and behavioral measures. The company…
Read More » -
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Royalty Pharma (NASDAQ:RPRX)
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry,…
Read More » -
CHINARES PHARMA’s Innovative Drug BGM0504 for Weight Loss Has NDA Accepted AASTOCKS Financial News
You expressly agree that the use of this app/website is at your sole risk. AASTOCKS.com Limited, HKEx Information Services Limited,…
Read More » -
Aurobindo Pharma shares fall after USFDA flags Eugia Unit III with OAI status
Shares of Aurobindo Pharma Ltd. declined on Monday, June 15, after the US Food and Drug Administration (USFDA) classified the…
Read More » -
Is UroGen Pharma a Stock to Sell After Its Chief Medical Officer Unloaded 5,222 Shares?
Mark Schoenberg, Chief Medical Officer of UroGen Pharma Ltd. (URGN +0.75%), reported the sale of 5,222 ordinary shares for a…
Read More » -
Alnylam Taps Generative AI And Nordic Expansion As Market Lags Targets
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Alnylam…
Read More » -
Stocks to Watch for June 15: Vedanta, Aurobindo Pharma, JSW Energy, Dr Reddy’s and more
From Vedanta’s demerged entities market debut to JSW Energy’s wholly owned subsidiary JSW Neo Energy Ltd commissioning the full 150…
Read More » -
Ascentage Pharma (SEHK:6855) Stock After New ASCO 2026 Data A Fresh Look At Valuation
Ascentage Pharma Group International (SEHK:6855) drew fresh market attention after presenting new ASCO 2026 data on olverembatinib in chronic myeloid…
Read More »